Jerusalem: The fourth dose of the Covid-19 vaccine increases five-fold antibodies a week after a shot given, Israeli Prime Minister Naphtali Bennett said on Tuesday, citing the initial findings of the Israeli study.
“A week into the fourth dose, we know the higher level of certainty that the fourth dose is safe,” Bennett said at the Sheba Medical Center, who gave a second booster shot in the trial among his staff in the midst of a surge in the omicron variant in the middle.
infection.
“Second pieces of news: We know that a week after administration of the fourth dose, we see a five-fold increase in the number of antibodies in people who are vaccinated,” he told reporters.
“This is likely to mean a significant increase in infection and …
hospitalization and symptoms (severe),” Bennett said in English.
Israel has played a major role in studying the impact of the Covid-19 vaccine, as the fastest country to launch two doses inoculation to a large population a year ago and one of the first gave the third shot as a booster.
Now given fourth dose to people over 60 years, health workers and immunocompromed patients.
The World Health Organization said more people around the world must be vaccinated with the first dose before others receive a booster.
Launched on December 27, Shaba’s trials gave the fourth dose of the Pfizer vaccine and Bionech to 150 medical personnel whose antibodies had dropped very since they received their third dose four to five months ago.
A separate group is set to receive moderna vaccines for their fourth dose this week, Sheba said.
Mild side effects of several participants have so far been reported no different from those reported after the third dose.
They include pain, fever and headaches, the hospital said.
Because the omicron variant which was very mutated was first detected in November, which showed data that had spread quickly and appeared at least 128 countries.
The case number has surged into the record of all time, but the level of hospitalization and death is largely lower than in other phases in pandemic.
In Israel, daily infections have increased more than 10 times for the past month.
Severe diseases have also risen but at a much slower speed, according to the Ministry of Health data.
About 60% of the 9.4 million state populations are fully vaccinated.
Some studies have indicated that even if Omicron escapes from antibodies, the key part of the defense of the two immune systems – the t-cell – still very effective to recognize and attack variants, preventing most infections to increase to critical illness.